Showing posts with label disease. Show all posts
Showing posts with label disease. Show all posts

Friday, February 10, 2012

Cigarettes, a case study in price discrimination (China vs. U.S.)

Economists predict there will be price discrimination when there is a monopolist supplier (or at least some degree of market power) and arbitrage between different groups of customers is costly. The United States tobacco market meets one of the two conditions - re-selling cigarettes without a license is barred by law - but the industry is still competitive between the large tobacco companies. In China, by contrast, both conditions are met because the China National Tobacco Company has a de facto monopoly on all cigarettes sold.

There is strong evidence of price differences between types of cigarettes sold in China. This paper by Li, et al, finds
...the price differential among brands is large. The self-reported cigarette price ranged from 0.70¥/pack to 100¥/pack, which gives smokers more choices in the price of cigarettes. In other words, Chinese smokers have more flexibility in choosing different prices of cigarettes than most Western smokers.
There are two, potentially complimentary stories to explain the wide difference in price of Chinese cigarettes. First is price discrimination to take advantage of different elasticities of demand between smokers; one person may value the marginal pack of cigarettes less than another. Charging lower prices for "inferior" brands of cigarettes will enhance monopoly profits, by selling a higher quantity at a lower price.

This type of price discrimination doesn't rely on direct knowledge about consumer preferences; the tobacco company can set a variety of prices, then smokers self-segregate according to their willingness to pay. Such a strategy would be less effective in the U.S. because cigarette taxes are so high, the relative price difference between brands is always comparatively small.

Another possibility is social signaling. In the United States, smoking is not a symbol of high status, in fact quite the opposite: it's more common that poor and uneducated people will be the ones who smoke. In China, gifts of tobacco are common and socially accepted, and expensive cigarettes are used to demonstrate affluence. By offering a wide range of prices for cigarettes, more different levels of social status can be signaled. One might expect that as general affluence in China increases, new forms of social signaling will become more popular instead.

Saturday, February 4, 2012

Komen Foundation Pilloried for Planned Parenthood Policy - and Rightly So

Earlier this week the Susan G. Komen for the Cure Foundation said they'd be eliminating their grants to Planned Parenthood for breast cancer screenings. The resulting social media uproar, however, quickly caused them to reverse that decision and issue a sickly-sweet apology press release.

I know blood in the water when I see it; my duty to the blogosphere wouldn't be met without helping to smear Komen's momentarily-vulnerable public image further. After all, it's not every day you can feel righteous while slinging mud on a charity.

The recent furor raises a broader question: how much of what the Komen Foundation does is actually getting us closer to a cure for breast cancer? According to their website, 84% is spent "on our mission." But, that "mission" is defined pretty broadly.

From Komen's donation page.

The screenings, research, and treatment services that Komen provides are definitely valuable, but those only make up 46% of the overall budget. That leaves 54% percent taken up by administration, fundraising and "education" (a.k.a. advertisements). Basically, for every dollar that Komen takes in, a little over half of it goes out toward seeking another dollar. It's inefficient.

Maybe "education" about the risk of breast cancer is important, and causes some people to get treatment who otherwise would not. But, there are obviously some diminishing returns to awareness. Breast and prostate cancer are the number two causes of cancer-related deaths for women and men, respectively, but breast cancer receives much more public money and attention.

Data source: Aminou R, Altekruse SF, Edwards BK, et al. SEER Cancer Statistics Review: 1975-2006. Cancer Statistics, National Cancer Institute. May 29, 2009

A cynic would say that it's more fun to talk about breasts than the inside of men's asses, and probably be right. Some recent "sexy" breast cancer awareness campaigns help to reinforce that cynical view. While the incidence of prostate cancer has risen rapidly over the last 20 years, much faster than the rate of breast cancer, the National Cancer Institute spent twice as much on breast cancer as it did on prostate cancer in 2008.

There shouldn't have to be a fight between different anti-cancer organizations for funding. All of these diseases deserve serious study and research toward a cure. But, there also shouldn't be pseudo-political organizations like the Komen Foundation sucking up resources for runs, pink ribbons, Facebook campaigns, "awareness", and other things commonly known to not stop cancer. If you want your donation to make a difference, write a check to a research lab, not a lobbying group. With their stance on Planned Parenthood, the Komen Foundation has revealed itself to be much closer to the latter.

Tuesday, September 14, 2010

Bedbugs. Yet another reason to hate Rachel Carson (aside from 800 million dead of malaria).

The history of malaria is interesting, in a macabre sort of way. A hardy parasite spread by insects, the cause of malaria was unknown for most of human history. The name we know today comes from the French phrase for "bad air," reflecting the common observation that malaria cases peaked around swampy areas. Their solution in Algeria - drain the swamps - was effective, but costly.

Malaria, the organism, is extremely difficult to kill. However its crucial vector, the mosquito, is vulnerable when combated with the correct chemical tool. In 1939, Paul Mueller discovered just that: DDT. This insecticide is cheap, effective, and quite safe for humans. Some claim it causes cancer, but their evidence has since been disputed. By comparison the malaria problem is undeniable and catastrophic, with millions dying on a yearly basis. As said by Wenceslaus Kilama, the Chairman of Malaria Foundation International "this is like loading up seven Boeing 747 airliners each day, then deliberately crashing them into Mt. Kilimanjaro."The imagery is hard to overlook.

The history of bed bugs is less interesting, but in a much more annoying way. Like malaria, bed bugs have plagued humanity since the dawn of time. They cause irritation, swelling, and definitely a terrible night's sleep. We're still combating this invasive parasite as well -- a national Pest Convention is meeting to discuss the issue. Exterminators have been caught by surprise as bed bug infestations have sprung up in the last several decades across the country, and surprisingly little is known about them.

What do malaria and bed bugs have in common? They've both been increasing since DDT usage was halted thanks to Rachel Carson's book, Silent Spring. Some people claim that bed bugs' modern upsurge is just due to increased travel. I think the facts say otherwise, given the almost total eradication of bed bug cases during the heyday of DDT's popularity. That issue aside, there's no disputing the deadly impact of malaria -- a plague that can easily be prevented by regular spraying of DDT.

The public outcry prior to the DDT ban is a classic example of action taken without full understanding of the consequences. Enough has been written on this already, so I won't belabor the point. Ultimately, Rachel Carson isn't the only one to blame; fault rests with the politicians and lobbyists who listened to her before all the evidence was in. Now, the public at large is feeling the consequences from decisions made forty years ago. With bed bugs infesting the Big Apple, maybe it will get people itching for change in our national pest control priorities.